1-6 of 6
Authors: Roy S. Herbst
Journal Article
Optimizing public-private partnerships to support clinical cancer research Get access
JNCI: Journal of the National Cancer Institute, djae279, https://doi.org/10.1093/jnci/djae279
Published: 12 December 2024
Journal Article
Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I
JNCI: Journal of the National Cancer Institute, Volume 115, Issue 4, April 2023, Pages 437–446, https://doi.org/10.1093/jnci/djad003
Published: 10 January 2023
Journal Article
E2F8 as a Novel Therapeutic Target for Lung Cancer
JNCI: Journal of the National Cancer Institute, Volume 107, Issue 9, September 2015, djv151, https://doi.org/10.1093/jnci/djv151
Published: 18 June 2015
Journal Article
Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 107, Issue 3, March 2015, dju435, https://doi.org/10.1093/jnci/dju435
Published: 03 February 2015
Journal Article
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 3, 8 February 2012, Pages 228–239, https://doi.org/10.1093/jnci/djr523
Published: 13 January 2012
Journal Article
Chemoradiotherapy With or Without AE-941 in Stage III Non–Small Cell Lung Cancer: A Randomized Phase III Trial Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 12, 16 June 2010, Pages 859–865, https://doi.org/10.1093/jnci/djq179
Published: 16 June 2010
